111 related articles for article (PubMed ID: 4082238)
1. A new approach to establishing individualized maintenance doses of phenytoin.
Bachmann K; Sullivan TJ; Schwartz J; Jauregui L
Ther Drug Monit; 1985; 7(4):391-400. PubMed ID: 4082238
[TBL] [Abstract][Full Text] [Related]
2. Use of plasma unbound drug concentrations in adjusting phenytoin doses.
Bachmann K; Voeller K; Forney R
Ther Drug Monit; 1984; 6(2):173-8. PubMed ID: 6740736
[TBL] [Abstract][Full Text] [Related]
3. Phenytoin as a probe of drug metabolism. Predicting clearance with a salivary sample.
Bachmann K; Schwartz J; Forney R; Jauregui L
Pharmacology; 1985; 30(3):145-52. PubMed ID: 3975264
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methods for the prediction of phenytoin concentrations.
Vázquez Rodríguez A; Santos Buelga D; Alonso González AC; Garcćia Sánchez MJ; Domínguez-Gil Hurlé A
J Clin Pharm Ther; 1991 Feb; 16(1):55-62. PubMed ID: 2026669
[TBL] [Abstract][Full Text] [Related]
5. Systematic approach to a dosage regimen for phenytoin based on one-point, steady-state plasma concentration.
Nakashima E; Matsushita R; Kido H; Nakamura M; Asahi M; Ichimura F
Ther Drug Monit; 1995 Feb; 17(1):12-8. PubMed ID: 7725371
[TBL] [Abstract][Full Text] [Related]
6. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
7. Comparison of single-point phenytoin dosage prediction techniques.
Yukawa E; Higuchi S; Ohtsubo K; Aoyama T
J Clin Pharm Ther; 1988 Aug; 13(4):293-305. PubMed ID: 3235480
[TBL] [Abstract][Full Text] [Related]
8. Phenytoin clearances in a compliant population: description and application.
Graves NM; Leppik IE; Termond E; Taylor JW
Ther Drug Monit; 1986; 8(4):427-33. PubMed ID: 3824428
[TBL] [Abstract][Full Text] [Related]
9. A graphical nomogram method for predicting toxic concentrations of unbound phenytoin.
Pospisil J; Pelclová D
Int J Clin Pharmacol Ther; 1994 Mar; 32(3):122-5. PubMed ID: 8205372
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of population pharmacokinetic parameters in phenytoin dosage adjustment.
Yukawa E; Higuchi S; Aoyama T
Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3363-6. PubMed ID: 2632085
[TBL] [Abstract][Full Text] [Related]
11. Single dose phenytoin clearance during erythromycin treatment.
Bachmann K; Schwartz JI; Forney RB; Jauregui L
Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):207-17. PubMed ID: 6515115
[TBL] [Abstract][Full Text] [Related]
12. Phenytoin dosage adjustment method using population clearance.
Yukawa E; Higuchi S; Aoyama T
Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):510-2. PubMed ID: 2337967
[TBL] [Abstract][Full Text] [Related]
13. Clinical rules for phenytoin dosing.
Privitera MD
Ann Pharmacother; 1993 Oct; 27(10):1169-73. PubMed ID: 7818614
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of single-point phenytoin dosage prediction methods in pediatric patients.
Yukawa E; Higuchi S; Aoyama T
J Pharmacobiodyn; 1988 Nov; 11(11):736-43. PubMed ID: 3236206
[TBL] [Abstract][Full Text] [Related]
15. Use of IV fosphenytoin pharmacokinetics to determine the loading dose for a clinical trial of canine status epilepticus.
Coles LD; Leppik IE; Patterson EE; Rivers Z; Mishra U; Cloyd JC
Epilepsia; 2015 Jun; 56(6):888-94. PubMed ID: 25952988
[TBL] [Abstract][Full Text] [Related]
16. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
[TBL] [Abstract][Full Text] [Related]
17. A method for prediction of phenytoin levels in the acute clinical setting.
Scheyer RD; Mattson RH
Comput Biomed Res; 1991 Dec; 24(6):564-75. PubMed ID: 1769232
[TBL] [Abstract][Full Text] [Related]
18. Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio.
Bourgeois BF; Wad N
Ther Drug Monit; 1985; 7(4):405-10. PubMed ID: 4082240
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of a new and simple technique for individualizing phenytoin dosage.
Yukawa E; Higuchi S; Aoyama T
J Pharmacobiodyn; 1989 Apr; 12(4):187-92. PubMed ID: 2795428
[TBL] [Abstract][Full Text] [Related]
20. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
Zielinski JJ; Haidukewych D; Leheta BJ
Ther Drug Monit; 1985; 7(1):51-3. PubMed ID: 3992622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
